Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Purdue’s Head Of R&D Has Broad Remit To Bring In New Assets

This article was originally published in The Pink Sheet Daily

Executive Summary

Newly appointed senior VP-R&D Alan Dunton is charged with curing the firm's dependency on pain products.


Related Content

Purdue CEO: The Year For Transformative M&A Is Here
People In The News: CEO Changes At Avalanche, Neurogastrx, Chase, Mannkind
Purdue Execs Plead Guilty To Misbranding OxyContin; Company Pays $700 Mil.


Related Companies